UB Paderborn / Katalog / Suche / in CDI

IDH mutation impairs histone demethylation and results in a block to cell differentiation

Nature (London), 2012-02, Vol.483 (7390), p.474-478

2012

Volltextzugriff (PDF)

Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma

Molecular cancer research, 2015-08, Vol.13 (8), p.1227-1237

2015

Volltextzugriff (PDF)

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells

Journal of neuro-oncology, 2010-05, Vol.97 (3), p.323-337

2010

Volltextzugriff (PDF)

Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-05, Vol.14 (5), p.613-623

2012

Volltextzugriff (PDF)

Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma

Blood advances, 2023-04, Vol.7 (7), p.1168-1177

2023

Volltextzugriff (PDF)

Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging

Journal of neurosurgery, 2007-09, Vol.107 (3), p.600-609

2007

Volltextzugriff (PDF)

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status

Journal of neuro-oncology, 2009-05, Vol.92 (3), p.373-386

2009

Volltextzugriff (PDF)

Constitutive EGFR signaling confers a motile phenotype to neural stem cells

Molecular and cellular neuroscience, 2003-12, Vol.24 (4), p.1116-1130

2003

Volltextzugriff (PDF)

Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models

Molecular cancer therapeutics, 2014-04, Vol.13 (4), p.867-879

2014

Volltextzugriff (PDF)

Mitogenic signaling cascades in glial tumors

Neurosurgery, 2003-06, Vol.52 (6), p.1425-1435

2003

Volltextzugriff (PDF)

EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53

Cancer biology & therapy, 2007-04, Vol.6 (4), p.571-579

2007

Volltextzugriff (PDF)

Receptor Tyrosine Kinase Signaling In Gliomagenesis: Pathobiology And Therapeutic Approaches

Cancer biology & therapy, 2003-07, Vol.2 (4), p.330-342

2003

Volltextzugriff (PDF)

Primary efficacy and safety of letetresgene autoleucel (lete-cel; GSK3377794) pilot study in patients with advanced and metastatic myxoid/round cell liposarcoma (MRCLS)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11500-11500

2022

Volltextzugriff (PDF)

Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-κB Activation through Gab1 in Glioblastoma Cells

Molecular and Cellular Biology, 2004-01, Vol.24 (2), p.823-836

2004

Volltextzugriff (PDF)

Critical Role of Diacylglycerol- and Phospholipid-Regulated Protein Kinase Cε in Induction of Low-Density Lipoprotein Receptor Transcription in Response to Depletion of Cholesterol

Molecular and Cellular Biology, 2002-06, Vol.22 (11), p.3783-3793

2002

Volltextzugriff (PDF)

Safety and Efficacy of Letetresgene Autoleucel (lete-cel; GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.3865-3865

2021

Volltextzugriff (PDF)

Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11521-11521

2021

Volltextzugriff (PDF)

Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies

Journal of medicinal chemistry, 2014-05, Vol.57 (9), p.3666-3677

2014

Volltextzugriff (PDF)

pp90RSK- and protein kinase C-dependent pathway regulates p42/44MAPK-induced LDL receptor transcription in HepG2 cells

Journal of lipid research, 2003-03, Vol.44 (3), p.584-593

2003

Volltextzugriff (PDF)

Abstract LB-212: IMAAGEN study biomarker analysis in patients with long term response to abiraterone acetate with prednisone for non-metastatic castrate resistant prostate cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-212-LB-212

2018

Volltextzugriff (PDF)

Whole exome sequencing (WES) of metastatic leiomyosarcoma (LMS) and liposarcoma (LPS) and correlation of genomic aberrations with clinical outcomes in the phase III randomized trial of trabectedin (T) vs. dacarbazine (D)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.11513-11513

2018

Volltextzugriff (PDF)

Activation of Raf-1/MEK-1/2/p42/44(MAPK) cascade alone is sufficient to uncouple LDL receptor expression from cell growth

Molecular and cellular biochemistry, 2002-07, Vol.236 (1-2), p.13-22

2002

Volltextzugriff (PDF)

391 Biomarker correlates of response in patients with advanced myxoid/round cell liposarcoma (MRCLS) treated with NY-ESO-1 TCR T cells (Letetresgene autoleucel)

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A424-A424

2021

Volltextzugriff (PDF)

Abstract LB-229: PTEN modulates EGFRvIII-mediated SHP-2 activation and translocation to affect glioblastoma sensitivity to tyrosine kinase inhibitors (TKI)

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.LB-229-LB-229

2010

Volltextzugriff (PDF)

Clinical qualification of plasma androgen receptor (p AR ) status and outcome on abiraterone acetate (AA) plus prednisone or dexamethasone (+P/D) in a phase II multi-institutional study in metastatic castration resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.5067-5067

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

IDH mutation impairs histone demethylation and results in a block to cell differentiation

Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells

Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma

Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma

Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status

Constitutive EGFR signaling confers a motile phenotype to neural stem cells

Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models

Mitogenic signaling cascades in glial tumors

EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53

Receptor Tyrosine Kinase Signaling In Gliomagenesis: Pathobiology And Therapeutic Approaches

Primary efficacy and safety of letetresgene autoleucel (lete-cel; GSK3377794) pilot study in patients with advanced and metastatic myxoid/round cell liposarcoma (MRCLS)

Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-κB Activation through Gab1 in Glioblastoma Cells

Critical Role of Diacylglycerol- and Phospholipid-Regulated Protein Kinase Cε in Induction of Low-Density Lipoprotein Receptor Transcription in Response to Depletion of Cholesterol

Safety and Efficacy of Letetresgene Autoleucel (lete-cel; GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma

Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis

Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies

pp90RSK- and protein kinase C-dependent pathway regulates p42/44MAPK-induced LDL receptor transcription in HepG2 cells

Abstract LB-212: IMAAGEN study biomarker analysis in patients with long term response to abiraterone acetate with prednisone for non-metastatic castrate resistant prostate cancer

Whole exome sequencing (WES) of metastatic leiomyosarcoma (LMS) and liposarcoma (LPS) and correlation of genomic aberrations with clinical outcomes in the phase III randomized trial of trabectedin (T) vs. dacarbazine (D)

Activation of Raf-1/MEK-1/2/p42/44(MAPK) cascade alone is sufficient to uncouple LDL receptor expression from cell growth

391 Biomarker correlates of response in patients with advanced myxoid/round cell liposarcoma (MRCLS) treated with NY-ESO-1 TCR T cells (Letetresgene autoleucel)

Abstract LB-229: PTEN modulates EGFRvIII-mediated SHP-2 activation and translocation to affect glioblastoma sensitivity to tyrosine kinase inhibitors (TKI)

Clinical qualification of plasma androgen receptor (p AR ) status and outcome on abiraterone acetate (AA) plus prednisone or dexamethasone (+P/D) in a phase II multi-institutional study in metastatic castration resistant prostate cancer (mCRPC)

Suchergebnisse filtern